This is a world’s première announced Thursday evening by Pixium Vision. The activation of its new retinal system implanted in the first patient, with atrophic dry age-related macular degeneration (AMD), allowed her to perceive light signals.
PRIMA, miniaturized wireless photovoltaic sub-retinal implant, elicited visual perception in the first human subject with Atrophic Dry-AMD
Innovation Days on Healthcare – Cité des sciences et de l’industrie, Paris, France, 26-28 January 2018
Healthcare of the future comes to the City of Science and Industry!
Pixium Vision receives FDA approval to begin human clinical study of its PRIMA retinal implant in the US
The feasibility clinical study is designed to evaluate PRIMA sub-retinalimplant in patients with Atrophic Dry Age-related Macular Degeneration